BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 18939388)

  • 1. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.
    Kim CH; Younossi ZM
    Cleve Clin J Med; 2008 Oct; 75(10):721-8. PubMed ID: 18939388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis and the cardiometabolic syndrome.
    Abdeen MB; Chowdhury NA; Hayden MR; Ibdah JA
    J Cardiometab Syndr; 2006; 1(1):36-40. PubMed ID: 17675901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: from pathogenesis to patient care.
    Perlemuter G; Bigorgne A; Cassard-Doulcier AM; Naveau S
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):458-69. PubMed ID: 17515890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in India - a lot done, yet more required!
    Duseja A
    Indian J Gastroenterol; 2010 Nov; 29(6):217-25. PubMed ID: 21191681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of fatty liver disease].
    Cobo Martín M; Fernández Gil P; Crespo J
    Gastroenterol Hepatol; 2008 Apr; 31(4):229-38. PubMed ID: 18405489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatty liver and global cardiometabolic risk].
    Szollár L
    Orv Hetil; 2010 Nov; 151(47):1946-50. PubMed ID: 21071306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonalcoholic fatty liver disease].
    Ko JS
    Korean J Gastroenterol; 2010 Jul; 56(1):6-14. PubMed ID: 20664312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Marzocchi R; Agostini F; Bugianesi E
    Curr Opin Lipidol; 2005 Aug; 16(4):421-7. PubMed ID: 15990591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
    Farrell GC; Larter CZ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake.
    Musso G; Gambino R; De Michieli F; Biroli G; Premoli A; Pagano G; Bo S; Durazzo M; Cassader M
    Am J Clin Nutr; 2007 Sep; 86(3):661-71. PubMed ID: 17823431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
    Yki-Järvinen H
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.